Lalitha Iyer - Concepedia

Author

Lalitha Iyer

Also Known As

Dr. Lalitha Iyer, I Danko, L IYER, L Iyer, L. Iyer, L. V. Iyer, L.V. Iyer, Lakshmi S. Iyer, Lalitha Iyer, Lalitha V Iyer

Publications

5.6K

Citations

H-Index

Concepts

All Affiliations

SRI International University of Chicago Loyola University Chicago St. Jude Children's Research Hospital University of Iowa

About

Lalitha Iyer is an author at SRI International specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	2.1K
2	Biochemistry	7	7	1K
3	Health Sciences	4	4	884
4	Natural Sciences	1	1	78
5	Endocrinology	1	1	27

Lalitha Iyer

Publications

4.5K

Citations

H-Index

Page 1

	Year	Citations
Genetic Variants in the <i>UDP-glucuronosyltransferase 1A1</i> Gene Predict the Risk of Severe Neutropenia of Irinotecan Federico Innocenti, Samir D. Undevia, Lalitha Iyer, Journal of Clinical Oncology	2004	946
UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity Lalitha Iyer, Soma Das, Linda Janisch, The Pharmacogenomics Journal Irinotecan DispositionMedicineGeneticsHuman PolymorphismMolecular Genetics	2002	711
Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes. Lalitha Iyer, Christopher D. King, P. F. Whitington, Journal of Clinical Investigation Aldo-keto ReductaseChemoprevention StrategyGeneticsMolecular BiologyPathology	1998	677
A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria Margaret A. Phillips, Julie Lotharius, Kennan C. Marsh, Science Translational Medicine	2015	367
Phenotype-genotype correlation of in vitro SN-38 (active metabolite of irinotecan) and bilirubin glucuronidation in human liver tissue with UGT1A1 promoter polymorphism Lalitha Iyer, Diana Hall, Sudip Das, Clinical Pharmacology & Therapeutics	1999	351
A Systematic Screen of FDA-Approved Drugs for Inhibitors of Biological Threat Agents Peter B. Madrid, Sidharth Chopra, Ian D. Manger, PLoS ONE	2013	253
Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7. Federico Innocenti, Lalitha Iyer, Mitchell D. Green, PubMed BiosynthesisBiotransformationBiochemistryMedicineLiver Physiology	2001	137
A parallel chiral–achiral liquid chromatographic method for the determination of the stereoisomers of ketamine and ketamine metabolites in the plasma and urine of patients with complex regional pain syndrome Ruin Moaddel, Swarajya Lakshmi Vattem Venkata, Mary J. Tanga, Talanta Pain ResearchPain DisordersHealth SciencesPain MedicineMedicine	2010	105
Flavopiridol metabolism in cancer patients is associated with the occurrence of diarrhea. Federico Innocenti, Walter M. Stadler, Lalitha Iyer, PubMed Gastrointestinal PharmacologyGastroenterologyPathologyPharmacotherapyCancer Patients	2000	80
Lead Optimization of 3-Carboxyl-4(1<i>H</i>)-Quinolones to Deliver Orally Bioavailable Antimalarials Yiqun Zhang, Julie Clark, Michele Connelly, Journal of Medicinal Chemistry Medicinal ChemistryPharmaceutical ScienceBioorganic ChemistryBiochemistryAntiparasitic Agent	2012	78

Page 1